Proposal to Add FDG-PET as an Outcome Measure for Clinical Trials in Patients With Prodromal Lewy Body Dementia
- 10 October 2023
- journal article
- editorial
- Published by Wolters Kluwer Health in Neurology
- Vol. 101 (15) , 666-667
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Cognitive and Brain Metabolism Profiles of Mild Cognitive Impairment in Prodromal Alpha-SynucleinopathyJournal of Alzheimer’s Disease, 2022
- Prodromal characteristics of dementia with Lewy bodies: baseline results of the MEMENTO memory clinics nationwide cohortAlzheimer's Research & Therapy, 2022
- FDG PET metabolic signatures distinguishing prodromal DLB and prodromal ADNeuroImage: Clinical, 2021
- Research criteria for the diagnosis of prodromal dementia with Lewy bodiesNeurology, 2020
- Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre studyBrain, 2019